The data described above, indicating that repressing BCL6 expression in activated CD8 T cells can benefit tumor control and may result in changes in CD8 T-cell effector function, encouraged us to compare MC38 tumor-infiltrating CD8 cells in Bcl6fl/fl and Bcl6fl/fl Gzmb-cre mice. This evidence concerns the gene CD8A and neoplasm.